AGL
Agilon Health, Inc.
AGL offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over AGL overall, supported by lower modeled downside and stronger valuation.
AGL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Under pressure | |
| Unavailable |
AGL's revenue and profitability are currently stable, but its cash flow is under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
AGL PE Valuation
AGL has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 59x next year's earnings.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
AGL Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
AGL has the edge over UNH on the outlook, with more favorable revenue expectations.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
AGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.86 | — |
| Q3 2026 | -$5.46 | +$13.21 |
| Q2 2026 | -$14.08 | +$5.09 |
| Q1 2026 | -$21.43 | -$6.70 |
| Q4 2025 | -$23.63 | -$7.80 |
| Q3 2025 | -$18.67 | +$4.76 |
| Q2 2025 | -$19.17 | -$0.88 |
| Q1 2025 | -$14.73 | +$2.69 |
| Q4 2024 | -$15.83 | +$0.22 |
AGL is still losing money, but far less than before: $5.46 per share over the past year, against $27.25 at its worst in late 2021.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over AGL on earnings quality, reporting a profit while its opponent remains loss making.
AGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.5B | +5.9% |
| Q2 2026 | $1.5B | +7.2% |
| Q1 2026 | $1.4B | -7.3% |
| Q4 2025 | $1.6B | +3.1% |
| Q3 2025 | $1.4B | -1.1% |
| Q2 2025 | $1.4B | -5.9% |
| Q1 2025 | $1.5B | -4.5% |
| Q4 2024 | $1.5B | +87% |
AGL's revenue grew through 2024 and has held roughly level since: $1.5B last quarter, up 5.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.6% | +11 points |
| Q2 2026 | 0.8% | +9.1 points |
| Q1 2026 | 0.3% | +1.7 points |
| Q4 2025 | -12% | -5.3 points |
| Q3 2025 | -9.2% | 0 points |
| Q2 2025 | -8.3% | -5.4 points |
| Q1 2025 | -1.4% | -1 points |
| Q4 2024 | -7.1% | +13 points |
AGL's operating margin was 1.6% last quarter, up 11 points from the same quarter a year ago, near the top of its range since 2020.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH has the edge over AGL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over AGL on profitability, with a higher operating margin.
AGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $46.6M | +$67.9M |
| Q2 2026 | -$60.7M | -$22.4M |
| Q1 2026 | $20.6M | +$56.5M |
| Q4 2025 | -$23.5M | -279% |
| Q3 2025 | -$21.3M | -$10.1M |
| Q2 2025 | -$38.3M | -$16.3M |
| Q1 2025 | -$35.8M | +$15.1M |
| Q4 2024 | $13.2M | +$78.3M |
AGL has burned cash in almost every quarter: −$17M over the past year, against −$82M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over AGL on cash generation, producing positive trailing cash flow while its opponent burns cash.
AGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.8% | +475K shares |
| 1 year | +6.7% | +1.1M shares |
| 3 years | +9% | +1.5M shares |
| 5 years | +13% | +2M shares |
| Available history | +15% | +2.3M shares |
AGL has 18M diluted shares, up 6.7% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2024 | — |
| Q3 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q4 2021 | — |
| Q1 2021 | — |
| Q3 2020 | $6.7M |
| Q2 2020 | — |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over AGL on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
AGL Net Leverage
AGL's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
AGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.8 | Neutral |
| Stochastic | 58.3 | Neutral |
AGL's weekly RSI is 64 (neutral) and its Stochastic is 58 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
AGL PE vs Healthcare Sector
AGL has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
AGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $91.3 | 21% above |
| 20 week MA | $96.3 | 15% above |
| 50 week MA | $61.7 | 79% above |
| 100 week MA | $59.8 | 85% above |
| 200 week MA | $181.6 | 39% below |
AGL has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 39% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
AGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $750.0 | $684.8 | -8.7% |
| 2022 | $684.8 | $407.0 | -41% |
| 2023 | $407.0 | $313.8 | -23% |
| 2024 | $313.8 | $47.5 | -85% |
| 2025 | $47.5 | $18.2 | -62% |
| 2026 YTD | $18.2 | $110.3 | +508% |
AGL has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.